Zhuo Zhao
Chongqing, 400038, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
α-hemolysin targets LGALS3 (galectin 3) to promote intracellular survival of Staphylococcus aureus via lysosomal disruption and autophagy inhibition.
Journal: Autophagy
Published: March 06, 2026
Vaccination with Carbapenemase KPC-2 and Virulence Factor Pal Provided Robust Protection Against Klebsiella pneumoniae Lung Infection.
Journal: Vaccines
Published: January 12, 2026
Integrated immunodominant epitope discovery for dual-purpose rapid and economical diagnostic and immunoprotective applications against MRSA.
Journal: Frontiers in immunology
Published: September 02, 2025
An epitope vaccine derived by analyzing clinical trial samples safeguards hosts with prior exposure to S. aureus against reinfection.
Journal: Science translational medicine
Published: August 20, 2025
From Sequence to System: Enhancing IVT mRNA Vaccine Effectiveness through Cutting-Edge Technologies.
From Sequence to System: Enhancing IVT mRNA Vaccine Effectiveness through Cutting-Edge Technologies.
Journal: Molecular pharmaceutics
Published: November 27, 2024
Alpha hemolysin enhances the immune response by modulating dendritic cell differentiation via ADAM10-Notch signaling.
Journal: Signal transduction and targeted therapy
Published: November 09, 2024
A rational designed multi-epitope vaccine elicited robust protective efficacy against Klebsiella pneumoniae lung infection.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: February 08, 2024
Host Immune Response to Clinical Hypervirulent Klebsiella pneumoniae Pulmonary Infections via Transcriptome Analysis.
Journal: Journal of immunology research
Published: April 28, 2022
Extracellular fibrinogen-binding protein released by intracellular Staphylococcus aureus suppresses host immunity by targeting TRAF3.
Journal: Nature communications
Published: January 31, 2022
α-Hemolysin-Aided Oligomerization of the Spike Protein RBD Resulted in Improved Immunogenicity and Neutralization Against SARS-CoV-2 Variants.
Journal: Frontiers in immunology
Published: August 12, 2021
Last Updated: 09/26/2026